Dr Recai Turkoglu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Investigation of the Effect of Ocrelizumab on Peripheral Lymphocyte Immunophenotypes with Suppressive Capacity in MS (NCT04874597) | Dr Recai Turkoglu | 2021-11-15 |
Track Dr Recai Turkoglu automatically
Every clearance here is in the API, with alerts when new ones post.